shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name
FRA-DIA-e29753f2-1,Z4661830643,C19H15ClN2O3,Racemic or presumed racemic or meso,354.787,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_A,ClC=1C=CC=2OCCC(C(=O)NC3=CC(=O)NC=4C=CC=CC34)C2C1,"6-chloro-N-(2-oxo-1,2-dihydroquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
MAT-POS-0c8fa4a7-1,Z4670228993,C20H15ClN2O,Achiral,334.798,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_B,ClC=1C=CC=2CCC=C(C(=O)NC=3C=NC=C4C=CC=CC34)C2C1,"7-chloro-N-(isoquinolin-4-yl)-3,4-dihydronaphthalene-1-carboxamide"
JAG-UCB-52b62a6f-11,Z4661830658,C17H15ClN4O2,Racemic or presumed racemic or meso,342.779,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_C,CC=1C=CN2C=NN=C2C1NC(=O)C3CCOC=4C=CC(Cl)=CC34,"6-chloro-N-{7-methyl-[1,2,4]triazolo[4,3-a]pyridin-8-yl}-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
JAG-UCB-52b62a6f-13,Z1675273451,C17H14ClN3O2,Racemic or presumed racemic or meso,327.764,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_D,ClC=1C=CC=2OCCC(C(=O)NC=3C=CC=C4C=NNC34)C2C1,"6-chloro-N-(1H-indazol-7-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
MAT-POS-53907a1c-2,Z4658934592,C24H32ClN3O2,Achiral,429.982,99,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_E,CC(C)OC=1C=C(Cl)C=C(C1)N(CCC2CCCCC2)C(=O)NC=3C=NC=CC3C,3-[3-chloro-5-(propan-2-yloxy)phenyl]-3-(2-cyclohexylethyl)-1-(4-methylpyridin-3-yl)urea
RAL-THA-6b94ceba-9,Z4609618486,C17H15ClN4O,Achiral,326.780,93,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_F,CC=1C=CN=CC1NC(=O)CC=2C=C(Cl)C=C(C2)C3=NC=CN3,2-[3-chloro-5-(1H-imidazol-2-yl)phenyl]-N-(4-methylpyridin-3-yl)acetamide
EDJ-MED-c8e7a002-4,Z2194341943,C15H13ClN4O,Achiral,300.742,95,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_G,CC=1C=CN2C=NN=C2C1NC(=O)CC=3C=CC=C(Cl)C3,"2-(3-chlorophenyl)-N-{7-methyl-[1,2,4]triazolo[4,3-a]pyridin-8-yl}acetamide"
MAR-UCB-f313ec4d-4,Z4655756141,C19H19N3O3,Achiral,337.372,95.28,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_H,COC=1C=CC=CC1NCCNC(=O)C2=CC(=O)NC=3C=CC=CC23,"N-{2-[(2-methoxyphenyl)amino]ethyl}-2-oxo-1,2-dihydroquinoline-4-carboxamide"
ALP-POS-a3de0cb1-14,Z4618924282,C22H22N4O2,Racemic or presumed racemic or meso,374.435,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_I,COC=1C=CC(=CC1)C(CC=2C=NN(C)C2)C(=O)NC3=CNC=4C=CC=CC34,N-(1H-indol-3-yl)-2-(4-methoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)propanamide
ALP-POS-87c86d55-1,Z4689476940,C20H20N6OS,Achiral,392.477,99,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_J,CN(C)C=1C=CC(=CC1)N(CC2=CSC=N2)C(=O)CN3N=NC=4C=CC=CC34,"2-(1H-1,2,3-benzotriazol-1-yl)-N-[4-(dimethylamino)phenyl]-N-[(1,3-thiazol-4-yl)methyl]acetamide"
MAT-POS-ea426761-52,Z2736056036,C17H21N5,Achiral,295.382,,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_K,CCCCC1=NC(=CN1)C2=NC=CN2CCC=3C=CC=CN3,"2'-butyl-1-[2-(pyridin-2-yl)ethyl]-1H,1'H-2,4'-biimidazole"
MAT-POS-ea426761-49,Z2736192471,C12H15F3N4,Achiral,272.269,,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_L,CCCCC1=NC(=CN1)C2=NC=CN2CC(F)(F)F,"2'-butyl-1-(2,2,2-trifluoroethyl)-1H,1'H-2,4'-biimidazole"
MAT-POS-ea426761-53,Z2736054246,C15H18N4O,Achiral,270.329,,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_M,CCCCC1=NC(=CN1)C2=NC=CN2CC=3C=COC3,"2'-butyl-1-[(furan-3-yl)methyl]-1H,1'H-2,4'-biimidazole"
MAR-UCB-195bc32d-16,Z1509140242,C12H14N2O2,Achiral,218.251,,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_N,CC(=O)NCCC1=CNC=2C=CC(O)=CC12,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide
EDJ-MED-c8e7a002-6,Z1205109041,C14H14ClN5O,Achiral,303.746,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_O,CC1=NN(C)C=2NN=C(NC(=O)CC=3C=CC=C(Cl)C3)C12,"2-(3-chlorophenyl)-N-{4,6-dimethyl-1H,6H-[1,2]diazolo[3,4-c]pyrazol-3-yl}acetamide"
ALP-POS-477dc5b7-2,Z4655756137,C19H16ClN3O,Racemic or presumed racemic or meso,337.802,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,03_P,ClC=1C=CC=2NCCC(C(=O)NC=3C=NC=C4C=CC=CC34)C2C1,"6-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroquinoline-4-carboxamide"
CHO-MSK-00c5269a-1,Z4664916425,C22H19ClN4O,Achiral,390.865,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,04_A,CC=1C=CC(=CC1)N(CC=2C=CC=C(Cl)C2)C(=O)CN3N=NC=4C=CC=CC34,"2-(1H-1,2,3-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-(4-methylphenyl)acetamide"
CHO-MSK-00c5269a-5,Z4664916430,C26H26ClN5O,Achiral,459.970,98.18,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,04_B,ClC=1C=CC=C(CN(C(=O)CN2N=NC=3C=CC=CC23)C=4C=CC(=CC4)N5CCCCC5)C1,"2-(1H-1,2,3-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-[4-(piperidin-1-yl)phenyl]acetamide"
JAG-UCB-52b62a6f-15,Z4661830691,C16H12BrClN4O2,Racemic or presumed racemic or meso,407.649,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,04_C,ClC=1C=CC=2OCCC(C(=O)NC3=NNC=4C=CN=C(Br)C34)C2C1,"N-{4-bromo-1H-pyrazolo[4,3-c]pyridin-3-yl}-6-chloro-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
RAL-THA-6b94ceba-7,Z4609618485,C16H16ClN3O2,Achiral,317.770,97.45,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,04_D,CNC(=O)C=1C=C(Cl)C=C(CC(=O)NC=2C=NC=CC2C)C1,3-chloro-N-methyl-5-{[(4-methylpyridin-3-yl)carbamoyl]methyl}benzamide
CHO-MSK-00c5269a-4,Z4664916429,C25H24ClN5O2,Achiral,461.943,98.98,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,04_E,ClC=1C=CC=C(CN(C(=O)CN2N=NC=3C=CC=CC23)C=4C=CC(=CC4)N5CCOCC5)C1,"2-(1H-1,2,3-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-[4-(morpholin-4-yl)phenyl]acetamide"
CHO-MSK-00c5269a-2,Z4664916427,C22H19ClN4O2,Achiral,406.864,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-27,04_F,COC=1C=CC(=CC1)N(CC=2C=CC=C(Cl)C2)C(=O)CN3N=NC=4C=CC=CC34,"2-(1H-1,2,3-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-(4-methoxyphenyl)acetamide"